Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 3 Warts 2 Neurofibromatosis 1 2 Neoplasms 2 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Retinoblastoma 1 Retinal Neoplasms 1 Prostatic Neoplasms 1 Port-Wine Stain 1 Pancreatic Neoplasms 1 Osteoma, Osteoid 1 Nevus of Ota 1 Neurofibromatoses 1 Neoplasm Metastasis 1 Mucositis 1 Lymphedema 1 Keratosis, Actinic 1 Hemangioma, Capillary 1 Head and Neck Neoplasms 1 Eye Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Bile Duct Neoplasms 1 Atrophy 1

Interventions

Docetaxel 292 Prednisone 240 enzalutamide 193 Leuprolide 185 Radiotherapy 179 Abiraterone Acetate 169 Magnetic Resonance Spectroscopy 163 bicalutamide 141 Goserelin 138 Androgen Antagonists 121 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108 Radiosurgery 108 apalutamide 92 gallium 68 PSMA-11 81 abiraterone 81 Specimen Handling 73 darolutamide 65 Surveys and Questionnaires 64 Gonadotropin-Releasing Hormone 63 Triptorelin Pamoate 58 Radiation 57 Biopsy 57 Brachytherapy 54 cabazitaxel 52 Standard of Care 51 Radiotherapy, Intensity-Modulated 51 Zoledronic Acid 50 pembrolizumab 49 luprolide acetate gel depot 49 Flutamide 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Lasers × Clear all

NCT06491056 2024-07-08

ProAMFocal

Singapore General Hospital

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡